Apatinib Dose Titration in Advanced or Metastatic Gastric Cancer

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 2, 2016

Primary Completion Date

December 10, 2018

Study Completion Date

April 15, 2019

Conditions

Gastric Cancer

Interventions

DRUG

Apatinib

Trial Locations (1)

Shanghai 6th People's Hospital, Shanghai

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT02764268 - Apatinib Dose Titration in Advanced or Metastatic Gastric Cancer | Biotech Hunter | Biotech Hunter